Lazuriton Nano Biotechnology (U.S.A.) Inc.: cashflow_operating
| Value | {"amount": -299736, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-06-30 |
| Status | current |
| Entity | Lazuriton Nano Biotechnology (U.S.A.) Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:07:30.346437+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9af692df-cbee-4799-8b19-4984e895f2db
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001640334-18-001644Retrieved: 2026-08-19T17:07:30.346437+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001666178/cashflow-operating/2017-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9af692df-cbee-4799-8b19-4984e895f2db
History
- supersedes {"amount": -299736, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"} (evidence 0001640334-17-001783)